FGFR1-amplified colorectal cancer: a distinct prognostic subtype identified through integrated genomic and immunohistochemical profiling.

ESMO Open · 2025 · PMC12529309 · PMID 40834499

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendP = 0.059so close (0.05 < p ≤ 0.1)

Consistent with this, TCGA-CRC data showed a trend toward reduced overall survival in FGFR 1 -altered cases ( P = 0.059) ( Supplementary Figure S5 A, available at https://doi.org/10.1016/j.esmoop.2025.105561 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.